Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate + UDCA in Primary Biliary Cholangitis
NCT06174402Phase 3Active, not recruiting
- Start
- Aug 2023
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenofibrate in primary biliary cholangitis (PBC). Started Aug 2023; status: active, not recruiting.
02
Drugs
fenofibrate
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT06174402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06174402.